HCP Company Profile (NYSE:HCP)

HCP trades on the New York Stock Exchange (NYSE) under the ticker symbol "HCP."

HCP declared a quarterly dividend on Thursday, July 27th. Shareholders of record on Monday, August 7th will be paid a dividend of $0.37 per share on Tuesday, August 22nd. This represents a $1.48 dividend on an annualized basis and a yield of 4.64%. View HCP's Dividend History.

HCP, Inc. (NYSE:HCP) released its earnings results on Tuesday, May, 2nd. The company reported $0.51 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.48 by $0.03. The business had revenue of $492.16 million for the quarter, compared to the consensus estimate of $514.82 million. HCP had a return on equity of 12.39% and a net margin of 41.38%. HCP's revenue was down 5.4% compared to the same quarter last year. During the same period last year, the company earned $0.69 EPS. View HCP's Earnings History.

HCP updated its FY17 earnings guidance on Tuesday, May, 2nd. The company provided earnings per share guidance of $1.89-1.95 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $1.93.

17 brokers have issued 12 month price targets for HCP's shares. Their predictions range from $30.00 to $38.00. On average, they expect HCP's share price to reach $32.69 in the next twelve months. View Analyst Ratings for HCP.

HCP saw a decrease in short interest in June. As of June 15th, there was short interest totalling 12,471,365 shares, a decrease of 16.4% from the May 31st total of 14,923,619 shares. Based on an average daily volume of 3,017,762 shares, the days-to-cover ratio is currently 4.1 days. Currently, 2.7% of the shares of the company are sold short.

Some companies that are related to HCP include Welltower (HCN), Ventas (VTR), Omega Healthcare Investors (OHI), Healthcare Trust of America (HTA), Medical Properties Trust (MPW), Healthcare Realty Trust Incorporated (HR), National Health Investors (NHI), Physicians Realty Trust (DOC), Care Capital Properties (CCP), LTC Properties (LTC), Assura PLC (AGR), Primary Health Properties PLC (PHP), MedEquities Realty Trust (MRT), Community Healthcare Trust Incorporated (CHCT), Aviv REIT (AVIV), CareTrust REIT (CTRE), Global Medical REIT (GMRE) and Sabra Healthcare REIT (SBRA).

HCP's management team includes the folowing people:

• Michael Dale McKee, Executive Chairman of the Board
• Thomas M. Herzog, Chief Executive Officer, Director
• Peter A. Scott, Chief Financial Officer, Executive Vice President
• Scott A. Anderson, Executive Vice President, Chief Accounting Officer
• Troy E. McHenry, Executive Vice President, General Counsel, Corporate Secretary
• Jonathan M. Bergschneider, Executive Vice President - Life Science Estates
• Thomas M. Klaritch CPA, Executive Vice President - Medical Office Properties
• Kendall K. Young, Executive Vice President - Senior Housing Investments
• Kai Hsiao, Senior Managing Director - Senior Housing Properties
• David B. Henry, Lead Independent Director

HCP's stock is owned by a variety of of institutional and retail investors. Top institutional investors include PGGM Investments (1.21%), APG Asset Management US Inc. (0.74%), Russell Investments Group Ltd. (0.49%), Hexavest Inc. (0.44%), NN Investment Partners Holdings N.V. (0.23%) and LGT Capital Partners LTD. (0.16%). Company insiders that own HCP stock include Darren A Kowalske, James Justin Hutchens, James P Hoffmann, Jonathan M Bergschneider, Kai Hsiao, Kendall K Young, Lauralee Martin, Peter L Rhein, Scott A Anderson, Thomas D Kirby and Thomas Klaritch. View Institutional Ownership Trends for HCP.

HCP's stock was sold by a variety of institutional investors in the last quarter, including Hexavest Inc., Meag Munich Ergo Kapitalanlagegesellschaft MBH, Sumitomo Mitsui Asset Management Company LTD, APG Asset Management N.V., Strs Ohio, Hartford Investment Management Co., Nisa Investment Advisors LLC and Pensionfund DSM Netherlands. Company insiders that have sold HCP stock in the last year include Darren A Kowalske, Jonathan M Bergschneider, Kendall K Young, Scott A Anderson, Thomas D Kirby and Thomas Klaritch. View Insider Buying and Selling for HCP.

HCP's stock was purchased by a variety of institutional investors in the last quarter, including APG Asset Management US Inc., Russell Investments Group Ltd., NN Investment Partners Holdings N.V., Real Estate Management Services LLC, Bank of Montreal Can, PGGM Investments, State of Alaska Department of Revenue and ING Groep NV. Company insiders that have bought HCP stock in the last two years include Darren A Kowalske, James Justin Hutchens, James P Hoffmann, Kendall K Young, Lauralee Martin and Thomas D Kirby. View Insider Buying and Selling for HCP.

Shares of HCP can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of HCP stock can currently be purchased for approximately $31.91.